Expanding Human Healthspan
A biotech lab developing science-backed longevity products.
We develop multi-compound formulations for age-related health challenges. Our research evaluates candidate formulations in preclinical in vivo models. These studies do not establish efficacy or safety in humans.
- 6in vivo models
- 200compounds phenotypically tested
- 170+research experiments
The problem
Health problems get worse with age.
Infertility
1 in 6
people are affected by infertility in their lifetime.
Source: WHO, 2023
Sexual function
39%
of women aged 40 to 80 report at least one sexual problem.
Source: Nicolosi et al., Urology, 2004
Sleep
1 in 4
Europeans over 50 have had sleep problems for 6+ months.
Heat
+63%
Heat-related deaths worldwide since the 1990s, now about 546,000 a year.
Source: Lancet Countdown, 2025
Menopause
Up to 80%
of women have hot flushes or night sweats.
Source: Avis et al., 2018
Most of these problems aren't classified as diseases, so few solutions are being developed
- No approved medical indication
- No incentive for pharma
- Limited academic funding
Why we are different
The best of both worlds.
The speed of supplements. The science of biotech.
-
Supplements
Fast to market.
Marketing-led development.
Focus
-
Speed + science.
Science-backed products.
Focus
-
Biotech
Deep science.
Longevity biotech.
Focus
How we work
From health problem to preclinical formulation assessment.
01
Identify the model
We pick health challenges that are not classified as diseases. Then we build in vivo models that reproduce them at the whole-body level, with phenotypic, physiologically relevant readouts.
02
Compound discovery
Using scientific literature, our own datasets and AI tools, we rank candidate compounds by their potential to act on the target biology.
03
Preclinical assessment and formulation
Candidates are tested in our models at our CRO. Findings in these models inform multi-compound formulation development; they do not establish benefit in humans.
Our in vivo studies are carried out by VivoArchitect Sàrl, a contract research organisation (CRO) in Lausanne.
Visit vivoarchitect.comOur own products
From our lab to your shelf.
Food supplements developed through our preclinical in vivo research platform.
Explore our products
* Spanish market packaging
Collaborate with us
Three ways to collaborate with us.
Preclinical research by us. Product development with you.
Validation.
VivoXpand R&D stamp
Our research stamp identifies the VivoXpand development platform; it is not a clinical certification.
We evaluate your existing product in preclinical in vivo models. Use of the VivoXpand stamp is subject to review; it does not certify human efficacy or safety.
Best for: brands that want to differentiate their product with in vivo scientific evidence.
Licensing.
Discuss licensing a formulation from our portfolio for your brand, with its documented evidence and the conditions for using the VivoXpand stamp.
Best for: brands that want a new product without building R&D.
Co-development.
We create the product and the brand with you, from concept to shelf.
- Health problem
- In vivo model
- Formulation
- Preclinical outcome assessment
- Regulatory and launch
Best for: companies with customer demand and distribution channels, but no product team
Our team
4 PhD scientists with +25 years combined experience in aging research.
A multidisciplinary team with expertise in aging, drug discovery and development, e-commerce, business and product development.
Create science-backed longevity products with us.
Talk to usRecognised and funded by leading organisations.
Organisations funding us
Our partners
